Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Jenck, F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lundstrom, K; Ziltener, P; Hermann, D; Schweitzer, C; Richards, JG; Jenck, F
      Improved Semliki Forest virus vectors for receptor research and gene therapy

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    2. Andreatini, R; Blanchard, C; Blanchard, R; Brandao, ML; Carobrez, AP; Griebel, G; Guimaraes, FS; Handley, SL; Jenck, F; Leite, JR; Rodgers, J; Schenberg, LC; Da Cunha, C; Graeff, FG
      The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    3. Higgins, GA; Grottick, AJ; Ballard, TM; Richards, JG; Messer, J; Takeshima, H; Pauly-Evers, M; Jenck, F; Adam, G; Wichmann, J
      Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function

      NEUROPHARMACOLOGY
    4. Rizzi, D; Bigoni, R; Rizzi, A; Jenck, F; Wichmann, J; Guerrini, R; Regoli, D; Calo, G
      Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    5. Dautzenberg, FM; Wichmann, J; Higelin, J; Py-Lang, G; Kratzeisen, C; Malherbe, P; Kilpatrick, GJ; Jenck, F
      Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Ouagazzal, AM; Jenck, F; Moreau, JL
      Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

      PSYCHOPHARMACOLOGY
    7. Jenck, F; Ouagazzal, AM; Pauly-Evers, M; Moreau, JL
      OrphaninFQ: role in behavioral fear responses and vulnerability to stress?

      MOLECULAR PSYCHIATRY
    8. Rover, S; Wichmann, J; Jenck, F; Adam, G; Cesura, AM
      ORL1 receptor ligands: Structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    9. Le Pen, G; Grottick, AJ; Higgins, GA; Martin, JR; Jenck, F; Moreau, JL
      Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia

      BEHAVIOURAL PHARMACOLOGY
    10. Kew, JNC; Koester, A; Moreau, JL; Jenck, F; Ouagazzal, AM; Mutel, V; Richards, JG; Trube, G; Fischer, G; Montkowski, A; Hundt, W; Reinscheid, RK; Pauly-Evers, M; Kemp, JA; Bluethmann, H
      Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site

      JOURNAL OF NEUROSCIENCE
    11. Wichmann, J; Adam, G; Rover, S; Hennig, M; Scalone, M; Cesura, AM; Dautzenberg, FM; Jenck, F
      Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    12. Jenck, F; Wichmann, J; Dautzenberg, FM; Moreau, JL; Ouagazzal, AM; Martin, JR; Lundstrom, K; Cesura, AM; Poli, SM; Roever, S; Kolczewski, S; Adam, G; Kilpatrick, G
      A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Rover, S; Adam, G; Cesura, AM; Galley, G; Jenck, F; Monsma, FJ; Wichmann, J; Dautzenberg, FM
      High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Jenck, F; Moreau, JL; Wichmann, J; Stadler, H; Martin, JR; Bos, M
      Brain 5-HT2C receptors: Potential role in anxiety disorders

      ANXIOLOYTICS
    15. Wichmann, J; Adam, G; Rover, S; Cesura, AM; Dautzenberg, FM; Jenck, F
      8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivativesas orphanin FQ receptor agonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    16. Jenck, F; Martin, JR; Moreau, JL
      The 5-HT1A receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats

      JOURNAL OF PSYCHOPHARMACOLOGY
    17. Koster, A; Montkowski, A; Schulz, S; Stube, EM; Knaudt, K; Jenck, F; Moreau, JL; Nothacker, HP; Civelli, O; Reinscheid, RK
      Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. JENCK F; MOREAU JL; BERENDSEN HHG; BEES M; BROEKKAMP CLE; MARTIN JR; WICHMANN J; VANDELFT AML
      ANTIAVERSIVE EFFECTS OF 5HT(2C) RECEPTOR AGONISTS AND FLUOXETINE IN AMODEL OF PANIC-LIKE ANXIETY IN RATS

      European neuropsychopharmacology
    19. MARTIN JR; MOREAU JL; JENCK F; PIERI L
      SARMAZENIL-PRECIPITATED WITHDRAWAL - A RELIABLE METHOD FOR ASSESSING DEPENDENCE LIABILITY OF BENZODIAZEPINE RECEPTOR LIGANDS

      Pharmacology, biochemistry and behavior
    20. MARTIN JR; BOS M; JENCK F; MOREAU JL; MUTEL V; SLEIGHT AJ; WICHMANN J; ANDREWS JS; BERENDSEN HHG; BROEKKAMP CLE; RUIGT GSF; KOHLER C; VANDELFT AML
      5-HT2C RECEPTOR AGONISTS - PHARMACOLOGICAL CHARACTERISTICS AND THERAPEUTIC POTENTIAL

      The Journal of pharmacology and experimental therapeutics
    21. BOS M; STADLER H; WICHMANN J; JENCK F; MARTIN JR; MOREAU JL; SLEIGHT AJ
      SYNTHESES OF O-METHYLASPARVENONE-DERIVED SEROTONIN-RECEPTOR ANTAGONISTS

      Helvetica Chimica Acta
    22. MOREAU JL; KILPATRICK G; JENCK F
      UROCORTIN, A NOVEL NEUROPEPTIDE WITH ANXIOGENIC-LIKE PROPERTIES

      NeuroReport
    23. BOS M; JENCK F; MARTIN JR; MOREAU JL; MUTEL V; SLEIGHT AJ; WIDMER U
      SYNTHESIS, PHARMACOLOGY AND THERAPEUTIC POTENTIAL OF 10-METHOXYPYRAZINO[1,2-A]INDOLES, PARTIAL AGONISTS AT THE 5HT(2C) RECEPTOR

      European journal of medicinal chemistry
    24. JENCK F; MOREAU JL; MARTIN JR; KILPATRICK GJ; REINSCHEID RK; MONSMA FJ; NOTHACKER HP; CIVELLI O
      ORPHANIN FQ ACTS AS AN ANXIOLYTIC TO ATTENUATE BEHAVIORAL-RESPONSES TO STRESS

      Proceedings of the National Academy of Sciences of the United Statesof America
    25. BOS M; JENCK F; MARTIN JR; MOREAU JL; SLEIGHT AJ; WICHMANN J; WIDMER U
      NOVEL AGONISTS OF 5HT(2C) RECEPTORS - SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED 2-(INDOL-1-YL)-1-METHYLETHYLAMINES AND 2-(INDENO[1,2-B]PYRROL-1-YL)-1-METHYLETHYLAMINES - IMPROVED THERAPEUTICS FOR OBSESSIVE-COMPULSIVE DISORDER

      Journal of medicinal chemistry
    26. JENCK F; MARTIN JR; MOREAU JL
      BEHAVIORAL-EFFECTS OF CCKB RECEPTOR LIGANDS IN A VALIDATED SIMULATIONOF PANIC ANXIETY IN RATS

      European neuropsychopharmacology
    27. MOREAU JL; BOS M; JENCK F; MARTIN JR; MORTAS P; WICHMANN J
      5HT(2C) RECEPTOR AGONISTS EXHIBIT ANTIDEPRESSANT-LIKE PROPERTIES IN THE ANHEDONIA MODEL OF DEPRESSION IN RATS

      European neuropsychopharmacology
    28. LUNDKVIST J; CHAI Z; TEHERANIAN R; HASANVAN H; BARTFAI T; JENCK F; WIDMER U; MOREAU JL
      A NON PEPTIDIC CORTICOTROPIN-RELEASING FACTOR-RECEPTOR ANTAGONIST ATTENUATES FEVER AND EXHIBITS ANXIOLYTIC-LIKE ACTIVITY

      European journal of pharmacology
    29. MARTIN JR; MOREAU JL; JENCK F
      ANIRACETAM REVERSES MEMORY IMPAIRMENT IN RATS

      Pharmacological research
    30. MOREAU JL; SCHERSCHLICHT R; JENCK F; MARTIN JR
      CHRONIC MILD STRESS-INDUCED ANHEDONIA MODEL OF DEPRESSION - SLEEP ABNORMALITIES AND CURATIVE EFFECTS OF ELECTROSHOCK TREATMENT

      Behavioural pharmacology
    31. MARTIN JR; MOREAU JL; JENCK F
      EVALUATION OF THE DEPENDENCE LIABILITY OF QUINOLIZINONES ACTING AS PARTIAL AGONISTS AT THE BENZODIAZEPINE RECEPTOR

      Drug development research
    32. JENCK F; MOREAU JL; MARTIN JR
      DORSAL PERIAQUEDUCTAL GRAY-INDUCED AVERSION AS A SIMULATION OF PANIC ANXIETY - ELEMENTS OF FACE AND PREDICTIVE-VALIDITY

      Psychiatry research
    33. MARTIN JR; JENCK F; MOREAU JL
      COMPARISON OF BENZODIAZEPINE RECEPTOR LIGANDS WITH PARTIAL AGONISTIC,ANTAGONISTIC OR PARTIAL INVERSE AGONISTIC PROPERTIES IN PRECIPITATINGWITHDRAWAL IN SQUIRREL-MONKEYS

      The Journal of pharmacology and experimental therapeutics
    34. MARTIN JR; MOREAU JL; JENCK F
      PRECIPITATED WITHDRAWAL IN SQUIRREL-MONKEYS AFTER REPEATED DAILY ORAL-ADMINISTRATION OF ALPRAZOLAM, DIAZEPAM, FLUNITRAZEPAM OR OXAZEPAM

      Psychopharmacology
    35. MOREAU JL; BOURSON A; JENCK F; MARTIN JR; MORTAS P
      CURATIVE EFFECTS OF THE ATYPICAL ANTIDEPRESSANT MIANSERIN IN THE CHRONIC MILD STRESS-INDUCED ANHEDONIA MODEL OF DEPRESSION

      Journal of psychiatry & neuroscience
    36. GRIEBEL G; MOREAU JL; JENCK F; MUTEL V; MARTIN JR; MISSLIN R
      EVIDENCE THAT TOLERANCE TO THE ANXIOGENIC-LIKE EFFECTS OF MCPP DOES NOT INVOLVE ALTERATION IN THE FUNCTION OF 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS

      Behavioural pharmacology
    37. MOREAU JL; BORGULYA J; JENCK F; MARTIN JR
      TOLCAPONE - A POTENTIAL NEW ANTIDEPRESSANT DETECTED IN A NOVEL ANIMAL-MODEL OF DEPRESSION

      Behavioural pharmacology
    38. JENCK F; MOREAU JL; MUTEL V; MARTIN JR
      BRAIN 5-HT1C RECEPTORS AND ANTIDEPRESSANTS

      Progress in neuro-psychopharmacology & biological psychiatry
    39. GRIEBEL G; MOREAU JL; JENCK F; MISSLIN R; MARTIN JR
      ACUTE AND CHRONIC TREATMENT WITH 5-HT REUPTAKE INHIBITORS - DIFFERENTIALLY MODULATE EMOTIONAL RESPONSES IN ANXIETY MODELS IN RODENTS

      Psychopharmacology
    40. GRIEBEL G; MOREAU JL; JENCK F; MARTIN JR; MISSLIN R
      SOME CRITICAL DETERMINANTS OF THE BEHAVIOR OF RATS IN THE ELEVATED PLUS-MAZE

      Behavioural processes
    41. MARTIN JR; MOREAU JL; JENCK F; CUMIN R
      ACUTE AND CHRONIC ADMINISTRATION OF BUSPIRONE FAILS TO YIELD ANXIOLYTIC-LIKE EFFECTS IN A MOUSE OPERANT PUNISHMENT PARADIGM

      Pharmacology, biochemistry and behavior
    42. MARTIN JR; SCHOCH P; JENCK F; MOREAU JL; HAEFELY WE
      PHARMACOLOGICAL CHARACTERIZATION OF BENZODIAZEPINE RECEPTOR LIGANDS WITH INTRINSIC EFFICACIES RANGING FROM HIGH TO ZERO

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 10:56:21